Research Article
Differential Plasma Proteins Identified via iTRAQ-Based Analysis Serve as Diagnostic Markers of Pancreatic Ductal Adenocarcinoma
Table 1
Clinical characteristics of patients included for iTRAQ and ELISA analyses.
| ||||||||||||||||||||||||||||||||||||||||||||||
BMI: body mass index; for iTRAQ and # for ELISA. |